Home About us Contact | |||
Gingival Index Scores (gingival + index_score)
Selected AbstractsOral health in preschool children with cerebral palsy: a case,control community-based studyINTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, Issue 5 2010RENNAN Y. DU International Journal of Paediatric Dentistry 2010; 20: 330,335 Objectives., To assess and compare the oral health status of preschool children with and without cerebral palsy (CP). Methods., Preschool children with CP (72) were recruited from 23 Special Child Care Centers in Hong Kong. An age (±3 months) and gender matched sample of preschool children from mainstream preschools were recruited as the control group. Dental caries status, gingival health status, tooth wear, developmental defect of enamel, malocclusion, dental trauma and oral mucosal health were assessed and compared between the two groups. Results., Significant differences in gingival health status were found between children with and without CP (mean plaque index scores, P = 0.001 and mean gingival index scores, P < 0.05). Tooth wear involving dentine was more prevalent among CP children (P < 0.001), as were evidence of anterior open-bite (P < 0.001) and oral mucosal lesions (P < 0.05). Children with and without CP had similar caries experiences (P > 0.05), prevalence of enamel defects (P > 0.05) and dental trauma (P > 0.05). Conclusions., Differences of oral health status exist among preschool children with and without CP. Preschool children fare worse in terms of gingival health, tooth wear, oral mucosal health and malocclusion. [source] Investigation of matrix metalloproteinase-1 ,1607 1G/2G polymorphism in a Turkish population with periodontitisJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 12 2008Kemal Ustun Abstract Aim: Matrix metalloproteinase-1 (MMP-1) is a proteolytic enzyme that degrades extracellular matrix and plays a fundamental role during destruction of periodontal tissues. The aim of this study was to examine the association between MMP-1 ,1607 1G/2G polymorphism and chronic periodontitis susceptibility in a Turkish population. Material and Methods: A total of 180 subjects were enrolled in this study. All the subjects received a periodontal examination including full-mouth clinical attachment loss measurements, probing depths, plaque index scores, gingival index scores and radiographic bone loss ratios. Three groups formed according to periodontal conditions were healthy, moderate periodontitis and severe periodontitis groups. MMP-1 ,1607 1G/2G gene promoter polymorphism was genotyped using a polymerase chain reaction-restriction fragment length polymorphism method. Results: Analysis of the polymorphism showed no differences in distribution of the MMP-1 ,1607 1G/2G polymorphism among healthy, moderate periodontitis and severe periodontitis groups (p>0.05). When the groups were further stratified by smoking status, we found no significant differences in genotype distributions, allele frequencies and carriage rates among any groups either (p>0.05). Conclusions: On the basis of the results, no significant association is found for the MMP-1 ,1607 1G/2G polymorphism with susceptibility to periodontitis. Moreover, smoking status did not seem to affect this result. [source] Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis: a phase-2 multi-center studyJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 2 2002Thomas Van Dyke Abstract Objective: P-113, a 12 amino acid histatin-based peptide, was evaluated in a mouthrinse formulation for safety and efficacy in a phase 2 multi-center clinical study. Method: 294 healthy subjects abstained from oral hygiene procedures and self-administered either 0.01% P-113, 0.03% P-113 or placebo mouthrinse formulations twice daily over a 4-week treatment period. During this time, the safety, anti-gingivitis, and anti-plaque effects of P-113 were evaluated. Results: There was a significant reduction in the change from baseline to Day 22 in bleeding on probing in the 0.01% P-113 treatment group of the intent to treat population (p=0.049). Non-significant trends in the reduction of the other parameters were observed in this population (p0.159). A sub-group of subjects which developed significant levels of disease within the four-week timeframe of the study was identified based on baseline gingival index scores 0.75. Significant findings were observed for bleeding on probing, gingival index and plaque index within this population (p<0.05). There were no treatment-related adverse events, and there were no adverse shifts in supragingival microflora during the study. Significant amounts of the peptide were retained in the oral cavity following rinsing. Conclusion: These data suggest that P-113 mouthrinse is safe and reduces the development of gingival bleeding, gingivitis and plaque in the human experimental gingivitis model. Zusammenfassung Ziel: In einer klinischen Phase-2 Multicenter-Studie wurde P-113, ein 12-Aminosäure-Histatin basierendes Peptid bezüglich Sicherheit und Effektivität in einer Mundspüllösung evaluiert. Methode:Für eine Behandlungszeitraum von 4 Monaten enthielten sich 294 Personen den Mundhygienemaßnahmen und spülten 2× täglich entweder mit 0.01% P-113, 0.03% P-113 oder mit einer Plazebolösung. Während dieser Zeit wurden die Sicherheit von P-113 sowie sein anti-Gingivitis- und sein anti-Plaqueeffekt evaluiert. Ergebnisse: In der 0.01% P-113-Behandlungsgruppe, der Population die behandelt werden sollte gab es eine signifikante Reduktion (p=0.049) der Veränderung zwischen Ausgangswert und Tag-22-Wert der Sondierungsblutung. In dieser Population wurden nichtsignifikante Trends in der Reduktion der anderen Parameter beobachtet (p0.159). Eine Untergruppe der Personen, welche während des vierwöchigen Zeitraumes ein signifikantes Erkrankungsniveau entwickelte, wurde auf der Grundlage eines Ausgangswertes für den Gingiva-Index von 0.75 identifiziert. Innerhalb dieser Population wurden signifikante Ergebnisse (p<0.05) für die Sondierungsblutung, den Gingiva-Index und den Plaque-Index beobachtet. Während dieser Studie gab es keine durch die Behandlung verursachten Nebenwirkungen und es gab keine unerwünschte Verschiebung der supragingivalen Mikroflora. Nach dem Spülen verblieb eine signifikante Menge des Peptids in der Mundhöhle. Schlussfolgerung: Diese Daten lassen annehmen, dass eine P-113-Mundspülössung sicher ist und die Entwicklung der Gingivablutung, Gingivitis und Plaque in einem humanen experimentellen Gingivitismodel hemmt. Résumé But: Le P-113, un peptide contenant de l'histatine a étéévalué dans un bain de bouche pour sa sécurité et son efficacité dans une étude multicentrique phase 2. Méthode. 294 sujets sains ont arrête toute hygiène buccale et se sont rincé avec soit 15 ml de P-113 0.01%, 15 ml de P-113 0.03% ou 15 ml d'une solution placebo 2× par jour durant une période de 4 semaines. Pendant ce temps, les effets anti-plaque et anti-gingivite, la sécurité ont étéévalués. Résultats: Il y avait une réduction significative entre l'examen de départ et le jour 22 dans le saignement au sondage dans le groupe P-113 0.01% (p=0.049). Aucune tendance significative dans la réduction des autres paramètres n'a été observée dans cette population (p0.159). Un sous-groupe de sujets qui développaient des niveaux significatifs de maladie durant ces 4 semaines a été identifié sur base de leur indice gingival initial 0.75. Des découvertes significatives ont été observées pour le saignement au sondage, l'indice gingival et l'indice de plaque dentaire dans cette population (p<0.05). Il n'y a eu aucun signe négatif dû au traitement ni aucune variation négative dans la flore sus-gingivale durant l'étude. Des quantités significatives du peptide ont été retenues dans la cavité buccale après rincage. Conclusion: Ces donnés suggèrent que le rincage au P-113 est sûr et réduit le dévelopement du saignement gingival, la gingivite et la plaque dentaire dans le modèle de la gingivite expérimentale humaine. [source] Gingival crevicular fluid and plasma levels of neuropeptide Substance-P in periodontal health, disease and after nonsurgical therapyJOURNAL OF PERIODONTAL RESEARCH, Issue 2 2009A. R. Pradeep Background and Objective:, The level of Substance-P in gingival crevicular fluid has been found to correlate with clinical measures of periodontal disease. The present study was designed to assess the relationship between clinical parameters and levels of Substance-P in the gingival crevicular fluid from inflamed gingiva, periodontitis sites and after treatment of periodontitis sites, and to correlate them to the Substance-P levels of plasma. Material and Methods:, Thirty, age- and gender-matched subjects were divided into three groups (healthy, gingivitis and chronic periodontitis) based on modified gingival index scores and clinical attachment loss. A fourth group consisted of 10 subjects from the periodontitis group, 6,8 wk after initial therapy. Plasma and gingival crevicular fluid samples were collected and quantified for Substance-P using an enzyme immunoassay. Results:, The mean concentration of Substance-P, both in gingival crevicular fluid and plasma, was observed to be highest in the periodontitis group (45.13 pg/mL in gingival crevicular fluid and 67.8 pg/mL in plasma) and lowest in the healthy group (6.07 pg/mL in gingival crevicular fluid and below the detection level in plasma). The mean Substance-P concentration in the gingivitis group (11.42 pg/mL in gingival crevicular fluid and 38.8 pg/mL in plasma) and in the after-treatment group (7.58 pg/mL in gingival crevicular fluid and 39.7 pg/mL in plasma) lay between the highest and lowest values. In all groups the gingival crevicular fluid levels showed a statistically significant positive correlation with that of plasma and clinical attachment loss. Conclusion:, Substance-P levels were highest in the gingival crevicular fluid from sites with periodontal destruction; however, periodontal treatment resulted in the reduction of Substance-P levels. Gingival crevicular fluid and plasma Substance-P levels showed a positive correlation in all of the groups. [source] Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitisJOURNAL OF PERIODONTAL RESEARCH, Issue 1 2005Hsein-Kun Lu Background:, The use of adjunctive minocycline with mechanical debridement in treating periodontitis has been widely studied using different methods. However, the results from these studies are equivocal. Objective:, The purpose of this study was to clarify the efficacy of the adjunctive use of subgingival minocycline application plus scaling/root planing as compared with the results of one episode of scaling/root planing in the treatment of chronic periodontitis. Methods:, Fifteen patients were enrolled in this split-mouth clinical trial. Probing depth, clinical attachment loss, gingival index, and bleeding on probing were evaluated at the baseline before scaling/root planing and 6, 10, 14, and 18 weeks later according to a single-blind protocol. The amount of interleukin-1, (interleukin-1, pg/site) at each lesion was also simultaneously measured in gingival crevicular fluid in a parallel comparison design. After full-mouth baseline measurements and scaling/root planing, 78 lesions with a residual mean probing depth of 5 mm at anterior teeth were selected and equally distributed in either right or left sites based on a split-mouth symmetrical design and randomly assigned to one of two treatment groups (with or without minocycline administration, n = 39 for each group). Results:, Probing depth significantly decreased from the baseline (week 0) to week 6 after scaling/root planing (p < 0.05) in both groups, but there was no statistically significant difference between the two groups (p > 0.05). However, at weeks 10, 14, and 18, the experimental group showed significantly greater improvement in pocket reduction than the control group (p < 0.05). Similarly, both groups also showed significant decreases in gingival index scores from weeks 0,6 (p < 0.05), but gingival index reductions at weeks 10, 14, and 18 were statistically significant in favor of the experimental group (p < 0.05). The experimental group had more attachment gain than the control group at weeks 14 and 18 (p < 0.05). Values of interleukin-1, (pg/site) at the experimental sites were significantly reduced at weeks 10, 14, and 18, as compared to values at control sites (p < 0.01). Finally, the incidence of bleeding on probing showed no differences between the two groups for any time interval (p > 0.05). Conclusions:, In this 18-week clinical trial, the results suggested that scaling/root planing with adjunctive subgingival administration of minocycline ointment has a significantly better and prolonged effect compared to scaling/root planing alone on the reduction of probing depth, clinical attachment loss, gingival index, and interleukin-1, content, but not on bleeding on probing. [source] |